ROXIAM ANTI-SCHIZOPHRENIC IS NEWEST STAR IN MERCK PHASE III FIRMAMENT; ASTHMA, OSTEOPOROSIS, GLAUCOMA DRUGS ADVANCING; PROSCAR NDA FILING NEAR

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".